2025 has arrived, and so has the promise of what #AI holds for the #lifesciences industry. Here are some of our predictions for the year ahead https://lnkd.in/eMVrNNMw
Intelligencia AI
Software Development
New York, New York 11,422 followers
Applying machine learning in drug development
About us
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
- Website
-
http://www.intelligencia.ai/
External link for Intelligencia AI
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Artificial Intelligence, Data Science, Machine Learning, Data Visualization, Experience Design, Healthcare, Pharmaceuticals, Biotechnology, Drug Development, and Clinical Trials
Locations
-
Primary
Get directions
180 Varick Street
6th Floor
New York, New York 10014, US
-
Get directions
Leoforos Syngrou 80-88
2nd Floor
Athens, Attiki 11741, GR
Employees at Intelligencia AI
-
Aristotelis Tsirigos
Professor at NYU School of Medicine.
-
Dimitrios Skaltsas
We are hiring! Co-Founder & CEO, Intelligencia AI: De-risking drug development| Inc. 5000| Executive in Residence, AI at INSEAD
-
Panos Karelis
Bringing best-in-class insights to biopharma | Director of Insights Excellence at Intelligencia.ai
-
Alexandra Ferraro
Strategic and Tactical Marketing Leader 💠 Data-Driven Strategist 💠 Market Expansion and Vertical Growth Leader 💠Experienced Full-Stack Marketing…
Updates
-
Read the latest from Pharmaceutical Executive's Michael Hollan featuring insights from Panos Karelis ➡️ https://lnkd.in/er-dZBAp "𝑇ℎ𝑒 𝑐𝑜𝑚𝑝𝑙𝑒𝑥𝑖𝑡𝑦 𝑖𝑠 𝑛𝑜𝑡 𝑜𝑛𝑙𝑦 𝑎𝑟𝑜𝑢𝑛𝑑 𝑡ℎ𝑒 𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚𝑠 𝑎𝑛𝑑 𝑡ℎ𝑒 𝑚𝑎𝑐ℎ𝑖𝑛𝑒 𝑙𝑒𝑎𝑟𝑛𝑖𝑛𝑔 𝑎𝑠𝑝𝑒𝑐𝑡𝑠, 𝑏𝑢𝑡 ℎ𝑜𝑤 𝑐𝑜𝑚𝑝𝑎𝑛𝑖𝑒𝑠 𝑏𝑢𝑖𝑙𝑑 𝑡ℎ𝑒𝑖𝑟 𝑑𝑎𝑡𝑎 𝑐𝑢𝑏𝑒𝑠, 𝑎𝑛𝑑 ℎ𝑜𝑤 𝑡ℎ𝑒𝑦 𝑐𝑜𝑙𝑙𝑒𝑐𝑡, 𝑠𝑡𝑟𝑢𝑐𝑡𝑢𝑟𝑒, 𝑎𝑛𝑑 ℎ𝑎𝑟𝑚𝑜𝑛𝑖𝑧𝑒 𝑡ℎ𝑎𝑡 𝑑𝑎𝑡𝑎 𝑠𝑜 𝑖𝑡 𝑏𝑒𝑐𝑜𝑚𝑒𝑠 𝐴𝐼-𝑟𝑒𝑎𝑑𝑦 𝑎𝑛𝑑 𝑐𝑎𝑛 𝑓𝑒𝑒𝑑 𝑡ℎ𝑒 𝑎𝑙𝑔𝑜𝑟𝑖𝑡ℎ𝑚𝑠. 𝑇ℎ𝑖𝑠 𝑚𝑢𝑠𝑡 𝑏𝑒 𝑑𝑜𝑛𝑒 𝑡𝑜 𝑒𝑛𝑠𝑢𝑟𝑒 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒𝑦 𝑔𝑒𝑛𝑒𝑟𝑎𝑡𝑒 𝑚𝑒𝑎𝑛𝑖𝑛𝑔𝑓𝑢𝑙 𝑎𝑛𝑑 𝑡𝑟𝑢𝑠𝑡𝑤𝑜𝑟𝑡ℎ𝑦 𝑜𝑢𝑡𝑝𝑢𝑡.”
-
Calling all #LLM Engineers: Our team is growing and looking for professionals driven by positively shaping the #healthcare and #pharmaceutical industry. Apply here: https://lnkd.in/evu9rqKg 💠Develop and optimize l arge language models to enhance our #AI capabilities 💠Work on cutting-edge projects to solve complex problems in clinical development 💠Collaborate with data scientists, researchers and engineers
Join Our Growing Team
intelligencia.ai
-
Are you looking for a new #podcast? 🎧 Tune in to Europe Builds featuring our CEO and co-founder, Dimitrios Skaltsas, as he shares his founder story and gives more insight into his why and the mission of Intelligencia AI. #AI #lifesciences #entrepreneur
We really can’t believe we’re already at Ep.7 of #EUROPEBUILDS 🎙️🥳 This week, we explore innovation at the crossroads of technology and #lifesciences with Dimitrios Skaltsas, Co-Founder and CEO of Intelligencia AI. Intelligencia AI is tackling one of the biggest challenges in drug development: de-risking innovation. By combining AI, machine learning, and deep scientific expertise, Dimitris and his team aim to bring life-changing therapies to patients faster. In this episode, we cover: 🔹 Balancing innovation with regulation in a complex industry. 🔹 Releasing AI tools at the right moment for impact. 🔹 Building trust-based relationships to bridge the gap between risk and discovery. 😲 And, here’s an interesting fact: EUROPE BUILDS is in the top 30% of video podcasts on Spotify—thank you for all the support! 🎧 Watch or listen now on Spotify, Apple Podcasts, and BORRN’s YouTube Channel (links in the comments)
-
-
2024 has been revolutionary for #AI, #healthtech, and pharma - from the first AI-designed drug entering clinical trials to groundbreaking Nobel Prize-winning AI advancements. What does 2025 hold? Read the predictions from our cross-functional experts here: https://lnkd.in/eMVrNNMw #Pharma2025 #lifesciences
2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
intelligencia.ai
-
As December marks Crohn's Disease Awareness month, we're sharing a snapshot of the current state of #drugdevelopment for this disease. #crohnsdisease For patient and caregiver resources, check out: 💠 Crohn's & Colitis Foundation 💠 Crohn's & Colitis UK
-
Here's your chance to make an impact in the #lifescience industry. If you have a passion for #innovation and a drive for #healthcare, apply today. 𝗦𝗲𝗻𝗶𝗼𝗿 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿: https://lnkd.in/eXAGDi_Y 💠Lead the development and execution of product strategies 💠Collaborate with cross-functional teams to deliver top-notch solutions 💠Drive product vision, go-to-market strategies and roadmap #jobopportunity #nowhiring
Join Our Growing Team
intelligencia.ai
-
As the 2024 American Society of Hematology Annual Meeting has come to a close, we made some bold predictions pre-conference that we confidently shared in the industry with our network of pharma and financial market leaders. 𝐎𝐮𝐫 𝐩𝐫𝐞-𝐀𝐒𝐇 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐨𝐧𝐬 𝐰𝐞𝐫𝐞 𝐯𝐚𝐥𝐢𝐝𝐚𝐭𝐞𝐝. 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐚𝐧 𝐢𝐧𝐜𝐫𝐞𝐝𝐢𝐛𝐥𝐞 𝐭𝐞𝐬𝐭𝐚𝐦𝐞𝐧𝐭 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐥𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟 𝐨𝐮𝐫 #𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 #𝐏𝐓𝐑𝐒 𝐚𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭𝐬 𝐚𝐬 𝐫𝐨𝐛𝐮𝐬𝐭 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐨𝐫𝐬 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐩𝐫𝐨𝐠𝐫𝐚𝐦 𝐬𝐮𝐜𝐜𝐞𝐬𝐬, 𝐞𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 𝐢𝐧 𝐭𝐡𝐞𝐢𝐫 𝐮𝐭𝐢𝐥𝐢𝐭𝐲 𝐟𝐨𝐫 𝐟𝐮𝐭𝐮𝐫𝐞 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐨𝐧𝐬. To read about our methodology, the sample #biotechs we highlighted and how such insights can drive better decisions and mitigate risks in #drugdevelopment, read it here: https://lnkd.in/eWCyuwnR #ASH2024 #ASH24 #hematology #oncology
ASH 2024: Validated Predictions With AI-Driven PTRS
intelligencia.ai
-
We’re excited to feature Andriana Aktypi in our employee profile series this month. Dive into her story to discover the most rewarding aspects of her role and how she taps her creative side in her free time. Read the interview here: https://lnkd.in/ezZCN6_z #CompanyCulture #EmployeeExperience #JoinOurTeam
-